(3)证监会反馈意见,保荐人、律师意见......................................................44
17、002144 宏达经编(股份公司设立前的员工持股会)...............................45
(1)持股形式..................................................................................................... 45
(2)规范途径..................................................................................................... 46
(3)证监会反馈意见,保荐人、律师意见......................................................46
18、002155 辰州矿业(工会与委托个人持股)...............................................46
(1)持股形式..................................................................................................... 46
(2)规范途径..................................................................................................... 46
(3)证监会反馈意见,保荐人、律师意见......................................................47
19、002159 三特索道(持股人数超 200)........................................................47
(1)持股形式..................................................................................................... 47
(2)规范途径..................................................................................................... 47
(3)证监会反馈意见,保荐人、律师意见......................................................48
20、002160 常铝股份(控股股东的职工持股会)...........................................48
(1)持股形式..................................................................................................... 48
(2)规范途径..................................................................................................... 48
(3)证监会反馈意见,保荐人、律师意见......................................................49
21、002165 红宝丽(内部职工股超比例、工会代持内部职工股和职工持股会同
时存在).............................................................................................................. 50
(1)持股形式..................................................................................................... 50
(2)规范途径..................................................................................................... 52
(3)证监会反馈意见,保荐人、律师意见......................................................53
22、002175 广陆数测(历史股东超 200)........................................................54
(1)持股形式..................................................................................................... 54
(2)规范途径..................................................................................................... 54
(3)证监会反馈意见,保荐人、律师意见......................................................54
23、002182 云海金属.......................................................................................... 55
24、002184 海德控制.......................................................................................... 56
25、002233 塔牌集团.......................................................................................... 57
26、002202 金风科技.......................................................................................... 58
(1)职工持股形式............................................................................................. 58
(2) 规范途径............................................................................................... 58
(3)证监会反馈意见,保荐人、律师意见......................................................59
27、通产丽星(002243.SZ)..............................................................................59
28、海陆重工(002255.SZ)..............................................................................60
29、升达林业(002259.SZ)..............................................................................61
30、恩华药业(002262.SZ)..............................................................................62
31、新华都(002264.SZ)..................................................................................63
32、华昌化工(002274.SZ)..............................................................................63
(三)委托持股案例................................................................................................... 65
1、002064 华峰氨纶............................................................................................ 65
2、002078 太阳纸业............................................................................................ 65
3、002082 栋梁新材............................................................................................ 67
4、002107 沃华医药(个人委托法人).............................................................68